card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Immunogenicity Testing in Biologics R&D: Whats your strategy?

Home / Insights / Immunogenicity Testing in Biologics R&D: Whats your strategy?

Immunogenicity testing and immunoassays can be a crucial component of your product's development and success. IQVIA Laboratories' bioanalytical and ADME services can meet your immunogenicity and immunoassay needs from method development and validation, through sample analysis and customized reporting.

Download our complimentary insight brief to learn about the importance of immunogenicity assays in biologics R&D, as well as a key step in interpreting a therapy's efficacy and safety. Having a partner that is staffed by scientists with extensive experience in design, development, and implementation of these immunogenicity assays in a clinical setting – as well as thorough knowledge of regulatory guidelines and best practices – is important in the rapidly growing healthcare landscape.

Author:
Paul Rhyne, Ph.D.

Complete the form below to access this insight brief